IL17A and metabolic dysfunction-associated steatotic liver disease: TH17 cells are known to expand in the liver of obese humans and mice [145], and multiple rodent models of NAFLD show increased IL-17A signaling through the IL-17A receptor (IL-17RA) [146,147].